Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.25.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net earnings $ 73,400 $ 168,105 $ 285,442
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation and amortization 109,903 111,711 107,238
Costs recognized on sale of acquired inventory 751 729 400
Deferred income taxes (51,107) (39,447) (29,567)
Stock-based compensation expense 40,833 38,042 39,230
Fair value adjustment to contingent consideration payable   (3,500) (12,100)
Gain on sale of CCXI investment     (37,176)
(Gain) Loss on equity method investment (938) 6,841 1,143
Asset impairment restructuring 21,312 2,634  
Gain on sale of Eminence     (11,682)
Leases, net 685 1,708 2,059
Impairment (recovery) of assets held-for-sale 80,503 21,963  
Other operating activity 675 301 (17)
Change in operating assets and operating liabilities, net of acquisition:      
Trade accounts and other receivables, net 34,132 (20,533) (20,867)
Inventories (18,144) (14,215) (30,167)
Prepaid expenses (14,372) (3,146) (4,585)
Trade accounts payable, accrued expenses, contract liabilities, and other (13,954) 25,769 (7,908)
Salaries, wages and related accruals 15,408 12,618 (24,558)
Income taxes receivable 8,469 (10,599) (2,492)
Net cash provided by (used in) operating activities 287,556 298,981 254,393
CASH FLOWS FROM INVESTING ACTIVITIES:      
Proceeds from sale of available-for-sale investments 1,085 28,083 35,236
Purchases of available-for-sale investments   (5,526) (20,500)
Proceeds from sale of CCXI investment     73,219
Additions to property and equipment (31,006) (62,877) (38,244)
Acquisitions, net of cash acquired   (169,707) (101,184)
Distributions from (Investments in) Wilson Wolf 7,291 6,997 (232,000)
Proceeds from sale of Eminence     17,824
Investment in Spear Bio (15,000)    
Proceeds from sale of assets held-for-sale 2,447    
Net cash provided by (used in) investing activities (35,183) (203,030) (265,649)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Cash dividends (50,391) (50,419) (50,285)
Proceeds from stock option exercises 51,739 60,935 29,813
Re-purchases of common stock (275,731) (80,042) (19,562)
Borrowings under line-of-credit agreement 104,000 225,000 619,661
Repayments of long-term debt (77,000) (256,000) (525,661)
Taxes paid on RSUs and net share settlements (6,522) (21,872) (28,893)
Other financing activity     (2,457)
Net cash provided by (used in) financing activities (253,905) (122,398) 22,616
Effect of exchange rate changes on cash and cash equivalents 11,927 (2,333) (3,356)
Net change in cash and cash equivalents 10,395 (28,780) 8,004
Cash and cash equivalents at beginning of period 151,791 180,571 172,567
Cash and cash equivalents at end of period $ 162,186 $ 151,791 $ 180,571